Please login to the form below

Not currently logged in
Email:
Password:

Dr June Raine continues as chair of EMA's pharmacovigilance committee

The PRAC also voted to extend Dr Almath Spooner's tenure asvice-chair

EMA PRAC Dr June RaineThe EMA has extended the tenure of Dr June Raine as chair for its Pharmacovigilance Risk Assessment Committee (PRAC).

Dr Raine is director of vigilance and risk management of medicines at the Medicines and Healthcare products Regulatory Agency (MHRA) and has served as PRAC chair since it was set up in 2012.

The Committee was established as part of a raft of pharmacovigilance reforms that aimed to make the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.

Dr Raine said: “It has been an enormous privilege to work with such a dedicated and talented group of scientists, regulators, healthcare professionals and patient representatives, from the first establishment of the PRAC three years ago.

“This is a truly exciting time for the Committee and I relish the opportunity to be part of leading this great initiative to better protect EU public health, to the high standards which every EU citizen can rightly expect.”

Under her leadership Dr Raine said the PRAC would have three key priorities:

• Evaluating the public health benefits of its pharmacovigilance activities and decisions
• Ensuring pharmacovigilance and risk management systems act as key enablers of earlier access for patients to innovative medicines
• Continuing to improve its engagement with healthcare professionals, patients and the public.

Alongside Dr Raine the EMA has also extended the term of the PRAC's vice-chair Dr Almath Spooner, who is also pharmacovigilance and risk management lead at the Ireland's Health Products Regulatory Authority.

22nd July 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics